Zeist, Netherlands

Eljo Y Van Battum

This inventor holds 1 USPTO granted patent. Top assignee: Interna Technologies B.v.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eljo Y Van Battum. Retrieved from https://idiyas.com/inventor/eljo-y-van-battum

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eljo Y Van Battum: Innovator in Neuronal Therapeutics

Introduction

Eljo Y Van Battum is a notable inventor based in Zeist, Netherlands. He has made significant contributions to the field of neuroscience through his innovative work on miRNA molecules. His research focuses on the therapeutic and diagnostic applications of these molecules in treating conditions associated with neuronal deficiencies.

Latest Patents

Eljo holds a patent for a miRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation. This invention relates to the diagnostic and therapeutic uses of a miRNA molecule, an equivalent, or a source thereof in addressing neuronal deficiencies and related diseases.

Career Highlights

Eljo is currently associated with Interna Technologies B.V., where he continues to advance his research in neuronal therapeutics. His work has garnered attention for its potential to improve the diagnosis and treatment of neurological conditions.

Collaborations

Eljo collaborates with talented individuals such as Vamshi R Vangoor and Alwin A H A Derijck, contributing to a dynamic research environment focused on innovative solutions in neuroscience.

Conclusion

Eljo Y Van Battum's contributions to the field of neuronal therapeutics highlight the importance of innovation in addressing complex medical challenges. His work exemplifies the potential of miRNA molecules in transforming the landscape of neurological treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…